Kael-GemVax Co., Ltd.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer (NCT01579188) | Kael-GemVax Co., Ltd. | 2012-05-01 |
| Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer (NCT00514072) | Kael-GemVax Co., Ltd. | 2007-03-01 |
Track Kael-GemVax Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.